Discovery of Regulators of Receptor Internalization with High-Throughput Flow Cytometry

被引:22
作者
Wu, Yang [1 ,2 ]
Tapia, Phillip H. [2 ]
Fisher, Gregory W. [4 ]
Simons, Peter C. [2 ]
Strouse, J. Jacob [2 ]
Foutz, Terry [2 ]
Waggoner, Alan S. [3 ,4 ]
Jarvik, Jonathan [3 ,4 ]
Sklar, Larry A. [1 ,2 ]
机构
[1] Univ New Mexico, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA
[2] Univ New Mexico, Sch Med, Ctr Mol Discovery, Albuquerque, NM 87131 USA
[3] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA
[4] Carnegie Mellon Univ, Technol Ctr Networks & Pathways, Pittsburgh, PA 15213 USA
基金
美国国家卫生研究院;
关键词
PROTEIN-COUPLED RECEPTORS; OBSTRUCTIVE PULMONARY-DISEASE; DRUG DISCOVERY; BETA(2)-ADRENERGIC RECEPTORS; FUNCTIONAL SELECTIVITY; SIGNAL-TRANSDUCTION; HUMAN BETA(1); ACTIVATION; AGONISTS; ANTAGONISTS;
D O I
10.1124/mol.112.079897
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We developed a platform combining fluorogen-activating protein (FAP) technology with high-throughput flow cytometry to detect real-time protein trafficking to and from the plasma membrane in living cells. The hybrid platform facilitates drug discovery for trafficking receptors such as G protein-coupled receptors and was validated with the beta(2)-adrenergic receptor (beta(2)AR) system. When a chemical library containing similar to 1200 off-patent drugs was screened against cells expressing FAP-tagged beta(2)ARs, all 33 known beta(2)AR-active ligands in the library were successfully identified, together with a number of compounds that might regulate receptor internalization in a nontraditional manner. Results indicated that the platform identified ligands of target proteins regardless of the associated signaling pathway; therefore, this approach presents opportunities to search for biased receptor modulators and is suitable for screening of multiplexed targets for improved efficiency. The results revealed that ligands may be biased with respect to the rate or duration of receptor internalization and that receptor internalization may be independent of activation of the mitogen-activated protein kinase pathway.
引用
收藏
页码:645 / 657
页数:13
相关论文
共 55 条
[31]   Impact of new technologies for cellular screening along the drug value chain [J].
Moeller, Clemens ;
Slack, Mark .
DRUG DISCOVERY TODAY, 2010, 15 (9-10) :384-390
[32]   β galactosidase complementation:: A cell-based luminescent assay platform for drug discovery [J].
Olson, Keith R. ;
Eglen, Richard M. .
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2007, 5 (01) :137-144
[33]   Opinion - How many drug targets are there? [J].
Overington, John P. ;
Al-Lazikani, Bissan ;
Hopkins, Andrew L. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (12) :993-996
[34]   N-Coumaroyldopamine and N-caffeoyldopamine increase cAMP via beta 2-adrenoceptors in myelocytic U937 cells [J].
Park, JB .
FASEB JOURNAL, 2005, 19 (06) :497-502
[35]   INTERACTION OF PALMITOYL CARNITINE WITH CALCIUM-ANTAGONISTS IN MYOCYTES [J].
PATMORE, L ;
DUNCAN, GP ;
SPEDDING, M .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 97 (02) :443-450
[36]  
PAUWELS PJ, 1988, MOL PHARMACOL, V34, P843
[37]   Differential effects of bucindolol and carvedilol on noradenaline-induced hypertrophic response in ventricular cardiomyocytes of adult rats [J].
Pönicke, K ;
Heinroth-Hoffmann, I ;
Brodde, OE .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (01) :71-76
[38]   High-throughput flow cytometry: Validation in microvolume bioassays [J].
Ramirez, S ;
Aiken, CT ;
Andrzejewski, B ;
Sklar, LA ;
Edwards, BS .
CYTOMETRY PART A, 2003, 53A (01) :55-65
[39]   Polyplexed Flow Cytometry Protein Interaction Assay: A Novel High-Throughput Screening Paradigm for RGS Protein Inhibitors [J].
Roman, David L. ;
Ota, Shodai ;
Neubig, Richard R. .
JOURNAL OF BIOMOLECULAR SCREENING, 2009, 14 (06) :610-619
[40]   I want a new drug: G-protein-coupled receptors in drug development [J].
Schlyer, Sabune ;
Horuk, Richard .
DRUG DISCOVERY TODAY, 2006, 11 (11-12) :481-493